Covaxin phase III trials from November
23 oct 2020
Vaccine maker Bharat Biotech has planned to conduct Phase III clinical trials for COVID 19 Covaxin from November 2020. This company is working in collaboration with Indian Council of Medical Research(ICMR). The trial is expected to be conducted on 26000 volunteers across 25 cities in India. This medicine has passed two phases of testing. Apart from Covaxin, other vaccines are on the way towards clinical trials including Serum Institute of India Drugmaker Dr. Reddy's laboratory which recently got DCGI approval to conduct the clinical trials of Russia's Sputnik-V vaccine.